PLAY PODCASTS
Overcoming Reluctance to Change as a Barrier to Optimizing ART for People Living With HIV and Viral Suppression
Episode 468

Overcoming Reluctance to Change as a Barrier to Optimizing ART for People Living With HIV and Viral Suppression

Don’t settle! Listen in as Dr Monica Gandhi and Dr Luis Buzon Martin discuss how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV.

Decera Clinical Education Infectious Disease Podcast · Luis Buzon Martin MD, Monica Gandhi MD MPH

October 16, 202523m 43s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Don’t settle! Listen in to learn how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV. Topics covered include:

  • International AIDS Society (IAS) USA and European AIDS Clinical Society (EACS) Guidance on Switching ART With Viral Suppression
  • Considerations for switching to a 2-drug regimen or long-acting ART
  • Methods for assessing patient satisfaction with their current ART regimen

Presenters:

Monica Gandhi, MD, MPH
Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
University of California, San Francisco (UCSF)
San Francisco, California

Luis Buzon Martin, MD
Division of Infectious Diseases
Hospital Universitario de Burgos
Burgos, Espana

Link to full program and accompanying slides: 
https://bit.ly/3KPN0xb

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

ddidolutegravircabotegravirla cab + rpvvirological suppressionlamivudineantiretroviral therapyart individualizationhiv-1pill burdendtg/rpvdrug-drug interactionquality of lifeart optimizationdtg/3tcartrilpivirinehivart switch